相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HLA-B*58:01 screening to prevent allopurinol-induced severe cutaneous adverse reactions in Chinese patients with chronic kidney disease
Christina Sze-Man Wong et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2022)
Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout
Edoardo Cipolletta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Increased risk of cardiovascular events and death in the initial phase after discontinuation of febuxostat or allopurinol: another story of the CARES trial
Byeong-zu Ghang et al.
RMD OPEN (2022)
Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4-5 chronic kidney disease not yet on dialysis
Sang-Hyon Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2020)
Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools
Faviel F. Gonzalez-Galarza et al.
NUCLEIC ACIDS RESEARCH (2020)
2020 American College of Rheumatology Guideline for the Management of Gout
John D. FitzGerald et al.
ARTHRITIS CARE & RESEARCH (2020)
Therapeutic approaches in the treatment of gout
Michael H. Pillinger et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease
Yueh-Lung Peng et al.
SCIENTIFIC REPORTS (2020)
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Isla S. Mackenzie et al.
LANCET (2020)
Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016
Man Fung Tsoi et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Effects of febuxostat on renal function in patients with chronic kidney disease A systematic review and meta-analysis
Tsu-Chen Lin et al.
MEDICINE (2019)
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
Carly A. Janssen et al.
RHEUMATOLOGY (2019)
Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
Fernando Perez Ruiz et al.
RMD OPEN (2019)
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
MaryAnn Zhang et al.
CIRCULATION (2018)
Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan
Kuang-Hui Yu et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study
Clotilde Loustau et al.
JOINT BONE SPINE (2018)
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout
Seoyoung C. Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Urate and the risk of Parkinson's disease in men and women
Marianna Cortese et al.
PARKINSONISM & RELATED DISORDERS (2018)
Diagnosis and Treatment of Gout and Pseudogout for Everyday Practice
Anthony Sidari et al.
PRIMARY CARE (2018)
Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies
Sharan K. Rai et al.
RHEUMATOLOGY (2018)
Efficacy and safety of febuxostat for treating hyperuricemia in patients with chronic kidney disease and in renal transplant recipients: A systematic review and meta-analysis
Xuzhong Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
Hyon Choi et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Hyperuricemia and dementia - a case-control study
Bettina Engel et al.
BMC NEUROLOGY (2018)
Joint Clinical Consensus Statement of the American College of Foot and Ankle Surgeons® and the American Association of Nurse Practitioners®: Etiology, Diagnosis, and Treatment Consensus for Gouty Arthritis of the Foot and Ankle
Roya Mirmiran et al.
JOURNAL OF FOOT & ANKLE SURGERY (2018)
Study of Therapeutic Efficacy of Febuxostat in Chronic Kidney Disease Stage IIIA to Stage VD
Partha Saradhi Sarvepalli et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2018)
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study
Hisashi Yamanaka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
A. John Camm et al.
HEART (2017)
Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis
Kuang-Hui Yu et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
The British Society for Rheumatology Guideline for the Management of Gout
Michelle Hui et al.
RHEUMATOLOGY (2017)
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study
Anne-Kathrin Tausche et al.
RHEUMATOLOGY (2017)
The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States
Eric Jutkowitz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review
Cristiana Caliceti et al.
NUTRIENTS (2017)
Effects of Febuxostat in Early Gout A Randomized, Double-Blind, Placebo-Controlled Study
Nicola Dalbeth et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial
Lisa K. Stamp et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study
Lisa K. Stamp et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
Sabrina M. Nielsen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout
Lisa K. Stamp et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
Y. Saito et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis
Shaobo Zhang et al.
CLINICAL RHEUMATOLOGY (2016)
Allopurinol hypersensitivity: investigating the cause and minimizing the risk
Lisa K. Stamp et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study
M. Nardin et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2016)
Gouty Arthritis: A Review of Acute Management and Prevention
Liza Wilson et al.
PHARMACOTHERAPY (2016)
Association of Serum Uric Acid and Disease Duration With Frequent Gout Attacks: A Case-Control Study
Abhishek Abhishek et al.
ARTHRITIS CARE & RESEARCH (2016)
Polymorphisms of uric transporter proteins in the pathogenesis of gout in a Chinese Han population
W. Wan et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Hyperuricemia starts at 360 micromoles (6 mg/dL)
Thomas Bardin
JOINT BONE SPINE (2015)
Allopurinol Use and Risk of Fatal Hypersensitivity Reactions A Nationwide Population-Based Study in Taiwan
Chien-Yi Yang et al.
JAMA INTERNAL MEDICINE (2015)
Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
Wen-Hung Chung et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Low-dose aspirin use and recurrent gout attacks
Yuqing Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction
Yugo Shibagaki et al.
HYPERTENSION RESEARCH (2014)
Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
John S. Sundy et al.
JOURNAL OF RHEUMATOLOGY (2014)
Effect of Urate-lowering Therapies on Renal Disease Progression in Patients with Hyperuricemia
Gerald D. Levy et al.
JOURNAL OF RHEUMATOLOGY (2014)
Clinical Characteristics of and Relationship Between Metabolic Components and Renal Function Among Patients with Early-onset Juvenile Tophaceous Gout
Chuan-Chin Lu et al.
JOURNAL OF RHEUMATOLOGY (2014)
Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
Surasak Saokaew et al.
PLOS ONE (2014)
Non-steroidal anti-inflammatory drugs for acute gout
Caroline M. P. G. van Durme et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
The Efficacy and Safety of Treatments for Acute Gout: Results from a Series of Systematic Literature Reviews Including Cochrane Reviews on Intraarticular Glucocorticoids, Colchicine, Nonsteroidal Antiinflammatory Drugs, and Interleukin-1 Inhibitors
Mihir D. Wechalekar et al.
JOURNAL OF RHEUMATOLOGY (2014)
Cardiovascular Risk Factors and Comorbidities in Patients with Hyperuricemia and/or Gout: A Systematic Review of the Literature
Caroline van Durme et al.
JOURNAL OF RHEUMATOLOGY (2014)
Interventions for Tophi in Gout: A Cochrane Systematic Literature Review
Melonie K. Sriranganathan et al.
JOURNAL OF RHEUMATOLOGY (2014)
Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout
Nicola Dalbeth et al.
BMC MUSCULOSKELETAL DISORDERS (2013)
Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones
David S. Goldfarb et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
M. S. Hershfield et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis
Peng Ye et al.
CLINICAL THERAPEUTICS (2013)
Efficacy and Tolerability of Probenecid as Urate-lowering Therapy in Gout; Clinical Experience in High-prevalence Population
Karen Pui et al.
JOURNAL OF RHEUMATOLOGY (2013)
Gout, Stone Composition and Urinary Stone Risk: A Matched Case Comparative Study
Giovanni Scala Marchini et al.
JOURNAL OF UROLOGY (2013)
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
Essack Mitha et al.
RHEUMATOLOGY (2013)
A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout
Labib I. Faruque et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra
Pradipta Ghosh et al.
ARTHRITIS CARE & RESEARCH (2013)
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
Sebastien Ottaviani et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
Robert A. Terkeltaub et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
Herbert S. B. Baraf et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Common dysfunctional variants in ABCG2 are a major cause of early-onset gout
Hirotaka Matsuo et al.
SCIENTIFIC REPORTS (2013)
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2012)
Association between HLA-B☆58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong
M. L. S. Chiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Reduced Glomerular Function and Prevalence of Gout: NHANES 2009-10
Eswar Krishnan
PLOS ONE (2012)
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
H. Ralph Schumacher et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study
Hyon K. Choi et al.
BRITISH MEDICAL JOURNAL (2012)
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Novel Evidence-Based Colchicine Dose-Reduction Algorithm to Predict and Prevent Colchicine Toxicity in the Presence of Cytochrome P450 3A4/P-Glycoprotein Inhibitors
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2011)
A two-stage approach to the treatment of hyperuricemia in gout: The Dirty Dish hypothesis
Fernando Perez-Ruiz et al.
ARTHRITIS AND RHEUMATISM (2011)
Gout and hyperuricemia in young people
Hisashi Yamanaka
CURRENT OPINION IN RHEUMATOLOGY (2011)
Risk factors for gout and prevention: a systematic review of the literature
Jasvinder A. Singh et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
Naomi Schlesinger et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Epidemiology of Gout in Women Fifty-two-Year Followup of a Prospective Cohort
Vidula Bhole et al.
ARTHRITIS AND RHEUMATISM (2010)
High Versus Low Dosing of Oral Colchicine for Early Acute Gout Flare Twenty-Four-Hour Outcome of the First Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Comparison Colchicine Study
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2010)
Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
Alexander So et al.
ARTHRITIS AND RHEUMATISM (2010)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
Robert L. Wortmann et al.
CLINICAL THERAPEUTICS (2010)
Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases
Kun Chen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
M. K. Reinders et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Frequency, Risk, and Cost of Gout-related Episodes Among the Elderly: Does Serum Uric Acid Level Matter?
Eric Q. Wu et al.
JOURNAL OF RHEUMATOLOGY (2009)
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
Wichittra Tassaneeyakul et al.
PHARMACOGENETICS AND GENOMICS (2009)
Colchicine Update: 2008
Robert A. Terkeltaub
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
A benefit-risk assessment of benzbromarone in the treatment of gout - Was its withdrawal from the market in the best interest of patients?
Ming-Han H. Lee et al.
DRUG SAFETY (2008)
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study
Hyon K. Choi et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Lowering serum uric acid levels:: What is the optimal target for improving clinical outcomes in gout?
Fernando Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients
Mattheus K. Reinders et al.
CLINICAL RHEUMATOLOGY (2007)
The changing epidemiology of gout
Edward Roddy et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout
Eliseo Pascual et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Effect of beer ingestion on the plasma concentrations and urinary excretion of purine bases: One-month study
Y. Moriwaki et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of long-term beer ingestion on plasma concentrations and urinary excretion of purine bases
T Ka et al.
HORMONE AND METABOLIC RESEARCH (2005)
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
JF Baker et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Obesity, weight change, hypertension, diuretic use, and risk of gout in men - The health professionals follow-up study
HK Choi et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid - The Third National Health and Nutrition Examination Survey
HK Choi et al.
ARTHRITIS AND RHEUMATISM (2005)
Purine-rich foods, dairy and protein intake, and the risk of gout in men
HK Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Beer, liquor, and wine consumption and serum uric acid level: The Third National Health and Nutrition Examination Survey
HK Choi et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy
A Shoji et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients
J Chanard et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Effect of beer on the plasma concentrations of uridine and purine bases
T Yamamoto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout
G Würzner et al.
JOURNAL OF HYPERTENSION (2001)
Relation between adverse events associated with allopurinol and renal function in patients with gout
J Vázquez-Mellado et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
分享论文
